bryan johnson glp 1 My magic mushroom longevity experiment found a metabolic reset button in the brain. We expected brain changes, but not a potential metabolic breakthrough. The discovery: my blood glucose control… Bryan Johnson, a tech billionaire

Diabetes Spectr Publ Am Diabetes Assoc

Writing Original Draft: BJ, Writing Review & Editing: MM, Editing: RK, RJ

What are the main side effects of Mounjaro

Involvement of d-amino acid oxidase in cerebral ischaemia induced by transient occlusion of the middle cerebral artery in mice

This ensures researchers can study GLP-1 therapies in populations that reflect real-world diversity, accounting for variations in age, ethnicity, socioeconomic status, and comorbid conditions

Over the past decade, pharmaceutical GLP-1 agonists (initially developed for type 2 diabetes) have demonstrated dramatic weight loss benefits when given at higher doses